Cargando…
Current and emerging pharmacological treatments for sarcoidosis: a review
The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short pe...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627473/ https://www.ncbi.nlm.nih.gov/pubmed/23596348 http://dx.doi.org/10.2147/DDDT.S31064 |
_version_ | 1782266315540529152 |
---|---|
author | Beegle, Scott H Barba, Kerry Gobunsuy, Romel Judson, Marc A |
author_facet | Beegle, Scott H Barba, Kerry Gobunsuy, Romel Judson, Marc A |
author_sort | Beegle, Scott H |
collection | PubMed |
description | The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short period of time. However, because sarcoidosis is often a chronic condition, long-term treatment with corticosteroids may cause significant toxicity. Therefore, corticosteroid sparing agents are often indicated in patients requiring chronic therapy. This review outlines the indications for treatment, corticosteroid treatment, and corticosteroid sparing treatments for sarcoidosis. |
format | Online Article Text |
id | pubmed-3627473 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36274732013-04-17 Current and emerging pharmacological treatments for sarcoidosis: a review Beegle, Scott H Barba, Kerry Gobunsuy, Romel Judson, Marc A Drug Des Devel Ther Review The treatment of sarcoidosis is not standardized. Because sarcoidosis may never cause significant symptoms or organ dysfunction, treatment is not mandatory. When treatment is indicated, oral corticosteroids are usually recommended because they are highly likely to be effective in a relative short period of time. However, because sarcoidosis is often a chronic condition, long-term treatment with corticosteroids may cause significant toxicity. Therefore, corticosteroid sparing agents are often indicated in patients requiring chronic therapy. This review outlines the indications for treatment, corticosteroid treatment, and corticosteroid sparing treatments for sarcoidosis. Dove Medical Press 2013-04-12 /pmc/articles/PMC3627473/ /pubmed/23596348 http://dx.doi.org/10.2147/DDDT.S31064 Text en © 2013 Beegle et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Review Beegle, Scott H Barba, Kerry Gobunsuy, Romel Judson, Marc A Current and emerging pharmacological treatments for sarcoidosis: a review |
title | Current and emerging pharmacological treatments for sarcoidosis: a review |
title_full | Current and emerging pharmacological treatments for sarcoidosis: a review |
title_fullStr | Current and emerging pharmacological treatments for sarcoidosis: a review |
title_full_unstemmed | Current and emerging pharmacological treatments for sarcoidosis: a review |
title_short | Current and emerging pharmacological treatments for sarcoidosis: a review |
title_sort | current and emerging pharmacological treatments for sarcoidosis: a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627473/ https://www.ncbi.nlm.nih.gov/pubmed/23596348 http://dx.doi.org/10.2147/DDDT.S31064 |
work_keys_str_mv | AT beeglescotth currentandemergingpharmacologicaltreatmentsforsarcoidosisareview AT barbakerry currentandemergingpharmacologicaltreatmentsforsarcoidosisareview AT gobunsuyromel currentandemergingpharmacologicaltreatmentsforsarcoidosisareview AT judsonmarca currentandemergingpharmacologicaltreatmentsforsarcoidosisareview |